Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

CV Sciences (CVSI) Total Non-Current Liabilities (2017 - 2024)

CV Sciences (CVSI) has disclosed Total Non-Current Liabilities for 9 consecutive years, with $6.1 million as the latest value for Q4 2024.

  • Quarterly Total Non-Current Liabilities fell 0.97% to $6.1 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $6.1 million through Dec 2024, down 0.97% year-over-year, with the annual reading at $6.1 million for FY2024, 0.97% down from the prior year.
  • Total Non-Current Liabilities hit $6.1 million in Q4 2024 for CV Sciences, roughly flat from $6.2 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $23.7 million in Q2 2020 to a low of $6.0 million in Q1 2024.
  • Historically, Total Non-Current Liabilities has averaged $12.8 million across 4 years, with a median of $9.9 million in 2022.
  • Biggest five-year swings in Total Non-Current Liabilities: surged 36.51% in 2020 and later tumbled 54.18% in 2023.
  • Year by year, Total Non-Current Liabilities stood at $19.4 million in 2020, then tumbled by 30.39% to $13.5 million in 2022, then crashed by 54.18% to $6.2 million in 2023, then dropped by 0.97% to $6.1 million in 2024.
  • Business Quant data shows Total Non-Current Liabilities for CVSI at $6.1 million in Q4 2024, $6.2 million in Q3 2024, and $6.3 million in Q2 2024.